Company research / KLRS
Kalaris Therapeutics, Inc. (KLRS)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2019-12-31, Kalaris Therapeutics, Inc. reported revenue of $165.0K.
Key ratios (year ended 2019-12-31)
-16182.4%
Operating margin
-14447.9%
Net margin
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.